Author:
Carrieri M. P.,Chesney M. A.,Spire B.,Loundou A.,Sobel A.,Lepeu G.,Moatti J. P.
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Altice, F., & Friedland,J. (1998). The eraofadherenceto antiretroviral therapy.Annals of Internal Medicine, 129, 503–505.
2. Avants, S. K., Margolin, A., Warburton, L. A., Hawkins, K. A., & Shi, J. (2001). Predictors of nonadherenceto HIV-related medication regimens during methadone stabilization.American Journal of Addiction, 10, 69–78.
3. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D.,Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.AIDS, 14, 357–366.
4. Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., et al. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.AIDS, 15, 1181–1183.
5. Bassetti, S., Battegay, M., Furrer, H., Rickenbach, M., Flepp, M., Kaiser, L., et al. (1999). Why ishighly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study.Journal of Acquired Immune Deficiency Syndromes, 21, 114–119.
Cited by
95 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献